Belite Bio, Inc (BLTE) Earnings History
Net Loss6 years of earnings data (2020–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Belite Bio, Inc (BLTE) Earnings Overview
As of June 24, 2026, Belite Bio, Inc (BLTE) reported trailing twelve-month net income of -$66M, reflecting -95.8% year-over-year growth. The company earned $-1.97 per diluted share over the past four quarters.
Looking at the long-term picture, BLTE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$6M in fiscal 2020.
Belite Bio, Inc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ACAD ($376M net income, 36.5% margin), REPL (-$315M net income), KRYS ($225M net income, 52.6% margin), BLTE has comparable earnings metrics. Compare BLTE vs ACAD →
BLTE Earnings vs Peers
Earnings metrics vs comparable public companies
BLTE Historical Earnings Data (2020–2025)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$78M | -114.7% | -$84M | $-2.31 | - | - |
| 2024 | -$36M | -14.3% | -$40M | $-1.18 | - | - |
| 2023 | -$32M | -150.1% | -$32M | $-1.19 | - | - |
| 2022 | -$13M | -30.9% | -$13M | $-0.63 | - | - |
| 2021 | -$10M | -68.0% | -$10M | $-0.40 | - | - |
| 2020 | -$6M | - | -$6M | $-0.62 | - | - |
Download Data
Export BLTE earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BLTE — Frequently Asked Questions
Quick answers to the most common questions about buying BLTE stock.
What is BLTE earnings per share (EPS)?
BLTE trailing twelve-month (TTM) diluted EPS is $-1.97, reflecting -95.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2020 to 2025 is available in the table on this page.
What is Belite Bio, Inc's net income?
Belite Bio, Inc (BLTE) trailing twelve-month net income is $-66M as of 2025. Earnings declined -95.8% year-over-year.
Is BLTE profitable?
BLTE is not currently profitable on a TTM basis, reporting a net loss of $-66M. Net margin is N/A. Investors should monitor for a return to profitability.
What is BLTE's earnings growth rate?
BLTE compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2020 to 2025.
What are BLTE's profit margins?
Belite Bio, Inc net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -16.9%.
Is BLTE growing earnings?
BLTE earnings are declining — EPS fell -95.8% year-over-year. TTM net income dropped to $-66M. This contrasts with the 5-year CAGR of N/A.
What was BLTE's best earnings year?
Belite Bio, Inc's highest annual net income on record is $-6M, achieved in fiscal year 2020. Earnings history on this page spans 2020 to 2025 and includes all annual and quarterly figures.
What were BLTE's earnings last quarter?
BLTE's most recent reported quarter was Q4 2025. Net income was $-25M with diluted EPS of $-0.72. For a full breakdown of all quarters, see the quarterly earnings table on this page.